Tercica

About:

Tercica, a biotechnology company, develops and commercializes therapeutics for the treatment of endocrine and metabolic diseases.

Website: http://www.ipsenus.com

Twitter/X: IpsenGroup

Top Investors: MPM Capital, Care Capital, Prospect Venture Partners, Kingsbridge Capital, Rho Ventures

Description:

Tercica Inc., a biotechnology company, engages in the development and commercialization of therapeutics for the treatment of endocrine and metabolic diseases. Its products include Increlex, an rDNA origin injection for the long-term treatment of children with short stature due to severe primary IGFD; and Somatuline Depot, a lanreotide injection for the treatment of adults with acromegaly. Tercica Inc. has strategic partnerships with Genentech and Ipsen SA. The company was founded in 2002 and is based in Brisbane, California. As of October 16, 2008, Tercica Inc. operates as a subsidiary of Ipsen S.A.